Schedule 13G ownership disclosure

INSMED INC

Common stock, par value $0.01 per share · CUSIP: 457669307

Event date: 2025-06-30

Filing-level shares
15,164,893
Percent of class
7.9%
  • JPMORGAN CHASE & CO.

    Shares: 15,164,893 · Class: 7.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000019617-25-000577
Form type
SCHEDULE 13G
Filer
INSMED Inc
CIK
CIK 1104506
Filed
Jul 30, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub